Literature DB >> 3772444

Intracranial malignant lymphoma. Report of 30 cases and review of the literature.

M Jiddane, F Nicoli, P Diaz, U Bergvall, F Vincentelli, J Hassoun, G Salamon.   

Abstract

Although primary malignant lymphoma is a rare entity in the gamut of intracranial tumors, it is more frequently seen than the secondary intracranial spread of a primary extracranial lymphoma. In general, the occurrence of lymphomas seems to be provoked by immunosuppression, as with medication (predominantly after transplantation) or with immunodepressive disease such as acquired immunodeficiency syndrome (AIDS). The usual age of onset of this disease is 55 to 65 years; and the male:female patient distribution is roughly 2:1. Characteristically, computerized tomography (CT) scans of lymphomas show a mass which is often large with regular contours, moderate mass effect, and hyper- or isodensity with marked and often homogeneous enhancement. In the series of 30 patients reported, the locations of lesions, in order of decreasing frequency, were the frontocallosal and temporal regions, the basal ganglia, and the cerebellum. Multiple lesions were present in 15% of these cases (20% to 40% in the literature). The following features should raise the suspicion of intracranial lymphoma: mirror lesions of the basal ganglia, bilateral subependymal infiltration, and leptomeningeal involvement contiguous with an intracerebral mass. According to the literature, the angiographic finding typical of lymphoma is an avascular tumor. A blush or vascular encasement of the mass seems to be rare, and the present series was in accordance with other reports in this respect. Differential diagnostic consideration should include meningioma, glioblastoma, metastatic disease, and focal infectious lesions such as toxoplasmosis or multifocal progressive leukoencephalitis, particularly in immunodepressed subjects. Diagnosing lymphoma from CT scans offers the alternative of substituting stereotaxic biopsy and neuropathological diagnosis for the more aggressive open surgical approach, since radiation therapy and possibly chemotherapy usually prove to be the treatment of choice.

Entities:  

Mesh:

Year:  1986        PMID: 3772444     DOI: 10.3171/jns.1986.65.5.0592

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  14 in total

1.  Primary central nervous system lymphoma imitates multiple sclerosis.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1990-10       Impact factor: 4.130

2.  Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain.

Authors:  M Watanabe; R Tanaka; N Takeda; K Wakabayashi; H Takahashi
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

3.  Non-Hodgkin's lymphoma involving the brain. Diagnostic usefulness of stereotactic needle biopsy in combination with paraffin-section immunohistochemistry.

Authors:  H Nakamine; H Yokote; T Itakura; S Hayashi; N Komai; Y Takano; K Saito; H Moriwaki; E Nishino; T Takenaka
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Diagnostic value of kinetic analysis using dynamic FDG PET in immunocompetent patients with primary CNS lymphoma.

Authors:  Yoshihiro Nishiyama; Yuka Yamamoto; Toshihide Monden; Yasuhiro Sasakawa; Nobuyuki Kawai; Katashi Satoh; Motoomi Ohkawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-29       Impact factor: 9.236

5.  Primary B-cell lymphoma of the CNS in an infant.

Authors:  J C Egelhoff; E C Beatty
Journal:  Pediatr Radiol       Date:  1989

6.  Diagnosis of primary cerebral lymphoma with particular reference to CT-guided stereotactic biopsy.

Authors:  W Feiden; K Bise; U Steude
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 7.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.

Authors:  S Dent; L Eapen; A Girard; H Hugenholtz; V DaSilva; D J Stewart
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

Review 9.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma.

Authors:  J Sawataishi; K Mineura; T Sasajima; M Kowada; A Sugawara; F Shishido
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.